Navigation Links
Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques
Date:10/13/2008

New 1.5 million dollar NIH funding advances study

Study needed because of low cardiac arrest survival rates

MINNEAPOLIS, Oct. 13 /PRNewswire/ -- Advanced Circulatory Systems, Inc. (http://www.advancedcirculatory.com) announced today that it has received an additional $1.5 million in funding from the National Institutes of Health (NIH) to continue a study testing two devices used in combination on those who experience cardiac arrest outside a hospital. Whatcom County, WA is one of six sites included in the national study.

The study is needed because of the dismally low survival rates for cardiac arrest; the national average for surviving such a cardiac arrest that occurs outside a hospital setting is only one in twenty.

The NIH funding will be used to increase enrollment in the six-site study. The study involves the testing of the ResQPump(R) an active compression/decompression device, in combination with the ResQPOD(R), a device used to increase blood flow to the heart and brain during CPR. The ResQPOD, an impedance threshold device proven to increase circulation, has previously received clearance from the FDA and is in use at more than 1,100 customer sites in the US. The current NIH funded study is the first randomized study in the US to assess results of the ResQPump and ResQPOD used together and comparing results when CPR is performed without these devices. The ResQPump has been tested and is currently in use in Europe. Both devices are designed and manufactured by Advanced Circulatory Systems of Minneapolis, MN.

The six sites involved in the study include Minneapolis, MN; St. Paul, MN; Whatcom County, WA; Oshkosh, WI; suburban Detroit including parts of Oakland and Macomb counties, MI; and Livingston County, MI which includes the city of Ann Arbor.

The use of new technologies as well as improved CPR procedures as recommended by the American Heart Association in its latest guidelines are intended to help more people survive a cardiac arrest and with their brain function intact. Studies like the NIH funded study are believed to be among the best methods to prove how treatments can impact outcomes.

Advanced Circulatory Systems' mission is to restore life and improve the quality of life for patients suffering cardiac arrest, low blood pressure and head injury by developing new technologies to non-invasively increase circulation throughout the body, providing improved opportunity for survival and quality of life. The privately held company is based in Minneapolis, MN.

Media contact: Joanne Henry, 612-843-2142, jhenry@henryschafer.com

Advanced Circulatory Systems medical contact: Keith Lurie, M.D., Chief Medical Officer, 952-947-9590, klurie@advancedcirculatory.com

The generally cleared indication for the ResQPOD is a temporary increase in blood circulation during emergency care, hospital, clinic and home use. Studies are ongoing in the United States to evaluate the long-term benefit of the ResQPOD for indications related to patients suffering from cardiac arrest, hypotension during dialysis and severe blood loss. The references in this communication are not intended to imply specific outcome-based claims not yet cleared by the US Food and Drug Administration. Clinical study references are available upon request.


'/>"/>
SOURCE Advanced Circulatory Systems
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region
2. Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)
3. Top Washington Health Officials to Honor Framingham Heart Study Participants
4. DuPont Provides Technology for Washington Hospital Centers Emergency Department
5. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
6. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
7. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
8. MedNet Solutions to Sponsor and Exhibit at the 2008 Advanced Medical Technology Association Conference in Washington, D.C.
9. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, Chile, ... their offering. ... Latin American pharmaceutical contract manufacturing services market is anticipated to ... registration cost in Latin American countries and continuous economic growth ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 ... Surgical drainage devices are tubes used to remove excess ... include, blood, serum, pus, urine, bile or lymph. Surgical ... types of surgery such as orthopedics surgery, cardiovascular surgery, ... device is prophylactic post-surgery to prevent accumulation of fluid ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... As part of the nationwide ... honor the victims of the Holocaust and Nazi persecution, Center for Medicine after ... Auschwitz on its CMATH Champions trip to Germany and Poland next week. , The ...
(Date:4/24/2017)... TX (PRWEB) , ... April 24, 2017 , ... The ... the glitterati, those unreal icons inhabiting the rarified air of pop and film stardom.(1) ... paparazzi and anyone snapping pictures: the smile. Grins now run the gamut from being ...
(Date:4/24/2017)... Calif. (PRWEB) , ... April 24, 2017 , ... The ... $1.6 million in charitable dental services to 1,961 people during the April 22-23 event ... at no charge to Californians who experience barriers to care, CDA Cares educates the ...
(Date:4/24/2017)... ... 24, 2017 , ... Veteran Theresa James awoke to the sound of her ... In “Healing Tears,” James depicts every parent’s worst nightmare, when her three children were ... conversations and situations throughout my divorce,” James said. “After the death of my children, ...
(Date:4/24/2017)... Boca Raton, Florida (PRWEB) , ... April 24, ... ... that develops a variety of unique liquid food supplements, announced its popular products ... of nutritional products. , ALP Nutrition® prioritizes the use of premium natural ...
Breaking Medicine News(10 mins):